A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia - more bactaeremias

Author： Young G.A.R.   Bosly A.   Gibbs D.L.   Durrant S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.8, 1999-08, pp. : 1208-1213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial

By Ozturk B.   Egehan I.   Atavci S.   Kitapci M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

By Awidi A.   Homsi U.   Kakail R.I.   Mubarak A.   Hassan A.   Kelta M.   Martinez P.   Sulaiti S.   Al Qady A.   Jamhoury A.   Daniel M.   Charles C.   Ambrose A.   El-Aloosy A.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2010-2014

Elsevier

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite